Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

ClinicalTrials.gov ID: NCT03823287

Public ClinicalTrials.gov record NCT03823287. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 12:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Neovascular Age-Related Macular Degeneration (TENAYA)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the efficacy, safety, durability, and pharmacokinetics of faricimab administered at intervals as specified in the protocol, compared with aflibercept once every 8 weeks (Q8W), in participants with neovascular age-related macular degeneration (nAMD).

Study identification

NCT ID
NCT03823287
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
671 participants

Conditions and interventions

Interventions

Drug · Procedure

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 19, 2019 (Actual)
Primary completion
Oct 26, 2020 (Actual)
Completion
Jan 18, 2022 (Actual)
Last update posted
Jul 23, 2025

2019 – 2022

United States locations

U.S. sites
52
U.S. states
24
U.S. cities
50
Facility City State ZIP Site status
Retinal Research Institute, LLC Phoenix Arizona 85014 —
Barnet Dulaney Perkins Eye Center Phoenix Arizona 85016 —
Retina Associates Southwest PC Tucson Arizona 85704 —
Retinal Diagnostic Center Campbell California 95008 —
The Retina Partners Encino California 91436 —
Jacobs Retina center at the Shiley eye Institute UCSD La Jolla California 92093 —
South Coast Retina Center Long Beach California 90807 —
Southern CA Desert Retina Cons Palm Desert California 92211 —
California Eye Specialists Medical group Inc. Pasadena California 91107 —
Retina Consultants, San Diego Poway California 92064 —
Retina Consultants of Southern California Redlands California 92373 —
University of California, Davis, Eye Center Sacramento California 95817 —
Retina Consultants of Southern Colorado Springs Colorado 80909 —
Retina Group of New England New London Connecticut 06320 —
Rand Eye Deerfield Beach Florida 33064 —
Florida Eye Associates Melbourne Florida 32901 —
Retina Specialty Institute Pensacola Florida 32503 —
Fort Lauderdale Eye Institute Plantation Florida 33324 —
Retina Vitreous Assoc of FL St. Petersburg Florida 33711 —
Northwestern Medical Group/Northwestern University Chicago Illinois 60611 —
Retina Associates Lenexa Kansas 66215 —
Johns Hopkins Med Baltimore Maryland 21287 —
Retina Group of Washington Chevy Chase Maryland 20815 —
Tufts Medical Center Boston Massachusetts 02111 —
Associated Retinal Consultants Grand Rapids Michigan 49546 —
Midwest Vision Research Foundation Chesterfield Missouri 63017 —
Retina Associates of St. Louis Florissant Missouri 63031 —
Sierra Eye Associates Reno Nevada 89502 —
NJ Retina Edison New Jersey 08820 —
Retina Associates of NJ Teaneck New Jersey 07666 —
Long Is. Vitreoretinal Consult Great Neck New York 11021 —
Ophthalmic Cons of Long Island Oceanside New York 11572 —
Retina Assoc of Western NY Rochester New York 14620 —
The Retina Consultants Slingerlands New York 12159 —
Retina Vit Surgeons/Central NY Syracuse New York 13224 —
Western Carolina Retinal Associate PA Asheville North Carolina 28803 —
Char Eye Ear &Throat Assoc Charlotte North Carolina 28210 —
Graystone Eye Hickory North Carolina 28602 —
Carolina Eye Associates Southern Pines North Carolina 28387 —
Cincinnati Eye Institute Cincinnati Ohio 45242 —
Retina Northwest Portland Oregon 97221 —
Mid Atlantic Retina - Wills Eye Hospital Philadelphia Pennsylvania 19107 —
Charleston Neuroscience Inst Ladson South Carolina 29456 —
Black Hills Eye Institute Rapid City South Dakota 57701 —
Charles Retina Institute Germantown Tennessee 38138 —
Tennessee Retina PC. Nashville Tennessee 37203 —
Texas Retina Associates Dallas Texas 75231 —
Retina & Vitreous of Texas Houston Texas 77025 —
Retina Consultants of Texas Houston Texas 77030 —
Valley Retina Institute P.A. McAllen Texas 78503 —
Rocky Mountain Retina Salt Lake City Utah 84107 —
Spokane Eye Clinical Research Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 109 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03823287, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 23, 2025 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03823287 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →